Alicia Grande Net Worth & Insider Trades
Alicia Grande - VP, Catalyst Pharmaceuticals, Inc
What is Alicia Grande's Net Worth?
The current estimated net worth of Catalyst Pharmaceuticals, Inc's VP, Alicia Grande, is estimated to be about $12.23M . Alicia Grande owns about 27,442 units of Catalyst Pharmaceuticals, Inc common stock. In the last 15 years at Catalyst Pharmaceuticals, Inc, Alicia Grande has sold an estimated value of $9.32M worth.
What is Alicia Grande's Past Insider Trading?
Alicia Grande's largest purchase order was 170,000 units , worth over $530.4K on August 19, 2021. Alicia Grande's largest sale order was 150,000 units , worth over $2.08M on August 19, 2022. In total, Alicia Grande has made about 36 transactions over 15 years of their time at Catalyst Pharmaceuticals, Inc. Alicia Grande usually trades in December, with the busiest year in 2022. The most recent transaction was a sale order of 120,000 units , worth over $1.98M on November 23, 2022.
Alicia Grande
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |
What is Alicia Grande's' Mailing Address?
- Mailing address is 220 Miracle Mile Suite 234 Coral Gables FL 33134 FL
Catalyst Pharmaceuticals, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Other Earnings Plans or Compensations
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Other Earnings Plans or Compensations
|
---|---|---|---|---|---|---|---|---|
Patrick J. McEnany | 2018 | $524,236 | $332,063 | $ | $3,461,504 | $3,461,504 | $ | $3,461,504 |
Steven R. Miller, COO and CSO | 2018 | $427,441409,325 | $188,600 | $ | $1,655,195 | $1,655,195 | $11,000 | $1,655,195 |
Gary Ingenito, CM&RO | 2018 | $399,373 | $194,810 | $ | $1,666,645 | $1,666,645 | $26,192 | $1,666,645 |
No matching records found |
Source: https://www.sec.gov/Archives/edgar/data/1369568/000119312520188818/d932120ddef14a.htm
What are Catalyst Pharmaceuticals, Inc's Past Insider Trades?
Catalyst Pharmaceuticals, Inc's most recent insider trade came on December 8, 2022 by Gary Ingenito who sold 5,918 units worth $99.72K . In the last 15 years, insiders at Catalyst Pharmaceuticals, Inc have sold an estimated value of $56.93M and bought an estimated value of $19.14M worth of shares. Insider trading is most common in December, with the busiest year in 2022. The most active traders at the company are Patrick J McEnany, President and CEO, Charles B. O'Keeffe, Director, and Philip H Coelho, Director .
CATALYST PHARMACEUTICALS, INC. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |